This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc.. Active years: 2012.
Company Filing History:
1 out of 3,069 
1 out of 1,422 
Years Active: 2012
Title: Junichi Hitomi: Innovator in Tricyclic Necrostatin Compounds
Introduction
Junichi Hitomi is a notable inventor based in Brookline, MA, who has made significant contributions to the field of pharmaceutical sciences. His work primarily focuses on developing compounds that address critical health issues related to cellular necrosis.
Latest Patents
Hitomi holds a patent for tricyclic necrostatin compounds. This invention features compounds, pharmaceutical compositions, and methods for treating trauma, ischemia, stroke, and degenerative diseases associated with cellular necrosis. Additionally, the patent describes screening assays for identifying compounds useful for treating these conditions.
Career Highlights
Throughout his career, Junichi Hitomi has worked with prestigious institutions, including Brigham and Women's Hospital and Harvard College. His research has contributed to advancements in understanding and treating various medical conditions.
Collaborations
Hitomi has collaborated with esteemed colleagues, including Junying Yuan and Alexei Degterev, enhancing the impact of his research through shared expertise and innovative ideas.
Conclusion
Junichi Hitomi's work in developing tricyclic necrostatin compounds showcases his dedication to improving healthcare through innovation. His contributions are vital in the ongoing fight against diseases associated with cellular necrosis.